(GRNY) Fundstrat Granny Shots US - Ratings and Ratios
US large-cap stocks, $10 billion+ companies, 80% allocation
| Risk via 10d forecast | |
|---|---|
| Volatility | 28.3% |
| Value at Risk 5%th | 50.8% |
| Relative Tail Risk | 9.22% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.55 |
| Alpha | 2.82 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.513 |
| Beta | 1.246 |
| Beta Downside | 1.220 |
| Drawdowns 3y | |
|---|---|
| Max DD | 24.18% |
| Mean DD | 4.06% |
| Median DD | 1.86% |
Description: GRNY Fundstrat Granny Shots US November 13, 2025
The Fundstrat Granny Shots US Large-Cap ETF (NYSE ARCA: GRNY) is an actively managed ETF that targets U.S. equities with market capitalizations above $10 billion. In typical market conditions it commits at least 80 % of its net assets-including any investment-purpose borrowings-to these large-cap stocks, aiming to capture broad-based growth while maintaining a large-blend exposure.
As of the most recent filing, GRNY carries an expense ratio of 0.45 % and holds roughly $350 million in assets under management, with the top five holdings concentrated in the technology, consumer discretionary, and health-care sectors-areas that historically account for about 45 % of the fund’s weight. Recent macro-economic indicators such as a 2.1 % annualized Q3 2024 GDP growth rate and the Federal Reserve’s policy stance (benchmark rate at 5.25-5.50 %) are key drivers of large-cap performance, while corporate earnings growth in the S&P 500 has averaged 8 % YoY, supporting the fund’s upside potential.
For a deeper quantitative breakdown of GRNY’s risk-adjusted returns and sector sensitivities, you might find ValueRay’s analytical tools useful for extending your research.
GRNY ETF Overview
| Market Cap in USD | 3,580m |
| Category | Large Blend |
| IPO / Inception | 2024-11-06 |
| Return 12m vs S&P 500 | 3.77% |
| Analyst Rating | - |
GRNY Dividends
Currently no dividends paidGRNY Growth Ratios
| Metric | Value |
|---|---|
| CAGR 3y | 16.21% |
| CAGR/Max DD Calmar Ratio | 0.67 |
| CAGR/Mean DD Pain Ratio | 3.99 |
| Current Volume | 7732.9k |
| Average Volume | 4898.8k |
What is the price of GRNY shares?
Over the past week, the price has changed by -4.73%, over one month by -7.39%, over three months by +1.86% and over the past year by +16.07%.
Is GRNY a buy, sell or hold?
What are the forecasts/targets for the GRNY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 24.6 | 4.6% |
GRNY Fundamental Data Overview November 21, 2025
Beta = 0.0
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 3.58b USD (3.58b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 3.58b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 3.58b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 10.61% (E(3.58b)/V(3.58b) * Re(10.61%) + (debt-free company))
Discount Rate = 10.61% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for GRNY ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle